Buprenorphine FAQ and Peer Discussion
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
Resource updated 09/14/2023
Resource updated 05/15/2024
Resource updated 05/17/2024
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
Resource from the RWHAP Best Practices Compilation updated on 03/20/2024
Resource updated 04/09/2024
Resource from the RWHAP Best Practices Compilation updated on 05/20/2024
Resource from the RWHAP Best Practices Compilation updated on 04/23/2024
Healthcare providers can receive no-cost expert clinical consultation in HIV prevention & care, HCV treatment, and substance use management.
Resource updated 09/20/2023
HIV clinical training resources for HRSA's AIDS Education and Training Centers Program.
Resource updated 04/17/2024
HIV-specific, validated tool to assess patient satisfaction with HIV primary care.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023
This resource is a tool for service and program monitoring.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023
CPAPA is no longer being updated by NASTAD and has been replaced by Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs.
Resource updated 10/31/2023
Tools developed by a Part A program to monitor programs and services.
Resource updated 09/19/2023
Resource for programs interested in developing or expanding outreach services to identify HIV-positive youth and engage and retain them in care.
Resource updated 09/20/2021
Federal guidelines for treatment, prevention and care of HIV disease, opportunistic infections, and common co-infections.
Resource updated 09/19/2023